1. Home
  2. CWD vs AIMD Comparison

CWD vs AIMD Comparison

Compare CWD & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CaliberCos Inc.

CWD

CaliberCos Inc.

HOLD

Current Price

$1.12

Market Cap

10.0M

Sector

Finance

ML Signal

HOLD

AIMD

Ainos Inc.

HOLD

Current Price

$1.39

Market Cap

9.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWD
AIMD
Founded
2009
1984
Country
United States
United States
Employees
N/A
44
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
9.8M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CWD
AIMD
Price
$1.12
$1.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
47.1K
21.5K
Earning Date
03-25-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,097,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$26.79
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.44
52 Week High
$46.21
$4.50

Technical Indicators

Market Signals
Indicator
CWD
AIMD
Relative Strength Index (RSI) 37.94 41.42
Support Level N/A $1.33
Resistance Level $1.55 $1.73
Average True Range (ATR) 0.12 0.12
MACD -0.02 0.01
Stochastic Oscillator 9.05 15.86

Price Performance

Historical Comparison
CWD
AIMD

About CWD CaliberCos Inc.

CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.

Share on Social Networks: